Javascript must be enabled to continue!
Abstract 3504: Regulation of cell cycle progression by Ikaros in leukemia
View through CrossRef
Abstract
Control of cell cycle progression is achieved by the coordinated function of a large set of genes that are highly conserved in eukaryotic organisms. Malignant cells have impaired regulation of cell cycle progression which results in uncontrolled cellular proliferation. Thus, understanding the regulation of cell cycle progression in malignant cells is essential to advance our knowledge of the process of malignant transformation and for designing novel treatments. Ikaros is a zinc finger protein that acts as a tumor suppressor in leukemia. The loss of Ikaros activity due to deletion or mutation has been associated with the development of high-risk B-cell acute lymphoblastic leukemia (B-ALL), as well as with T-cell ALL and acute myelogenous leukemia (AML). Ikaros binds DNA and regulates transcription of its target genes via chromatin remodeling. The mechanism of Ikaros tumor suppressor activity is largely unknown. Here, we present evidence that Ikaros regulates cell cycle progression in leukemia. Using quantitative Chromatin Immunoprecipitation assay (qChIP), we demonstrate that Ikaros binds in vivo to promoter regions of several genes that regulate cell cycle progression in B-ALL cell lines and in primary cells from patients with B-ALL. To study how Ikaros regulates transcription of these genes, luciferase reporter assays were performed. The promoter regions of three Ikaros target genes were cloned into luciferase reporter constructs. Each of these constructs has been co-transfected with Ikaros or an empty vector (as a negative control) into HEK 293T cells. Results showed that Ikaros represses transcription of the three genes that promote cell cycle progression. Overexpression of Ikaros in leukemia cells by retroviral transduction results in reduced transcription of the cell cycle promoting genes, as evidenced by quantitative real-time PCR (qRT-PCR), as well as cell cycle arrest. These data suggest that Ikaros regulates cell cycle progression in leukemia by direct repression of the transcription of the genes that promote cell cycle progression, and identifies one mechanism of Ikaros function as a tumor suppressor in leukemia.
Citation Format: Elanora Dovat, Jonathon Payne, Carlos M. Casiano, Justin Sloane, Chandrika Gowda, Kimberly J. Payne, Sinisa Dovat, Chunhua Song. Regulation of cell cycle progression by Ikaros in leukemia. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3504. doi:10.1158/1538-7445.AM2014-3504
American Association for Cancer Research (AACR)
Title: Abstract 3504: Regulation of cell cycle progression by Ikaros in leukemia
Description:
Abstract
Control of cell cycle progression is achieved by the coordinated function of a large set of genes that are highly conserved in eukaryotic organisms.
Malignant cells have impaired regulation of cell cycle progression which results in uncontrolled cellular proliferation.
Thus, understanding the regulation of cell cycle progression in malignant cells is essential to advance our knowledge of the process of malignant transformation and for designing novel treatments.
Ikaros is a zinc finger protein that acts as a tumor suppressor in leukemia.
The loss of Ikaros activity due to deletion or mutation has been associated with the development of high-risk B-cell acute lymphoblastic leukemia (B-ALL), as well as with T-cell ALL and acute myelogenous leukemia (AML).
Ikaros binds DNA and regulates transcription of its target genes via chromatin remodeling.
The mechanism of Ikaros tumor suppressor activity is largely unknown.
Here, we present evidence that Ikaros regulates cell cycle progression in leukemia.
Using quantitative Chromatin Immunoprecipitation assay (qChIP), we demonstrate that Ikaros binds in vivo to promoter regions of several genes that regulate cell cycle progression in B-ALL cell lines and in primary cells from patients with B-ALL.
To study how Ikaros regulates transcription of these genes, luciferase reporter assays were performed.
The promoter regions of three Ikaros target genes were cloned into luciferase reporter constructs.
Each of these constructs has been co-transfected with Ikaros or an empty vector (as a negative control) into HEK 293T cells.
Results showed that Ikaros represses transcription of the three genes that promote cell cycle progression.
Overexpression of Ikaros in leukemia cells by retroviral transduction results in reduced transcription of the cell cycle promoting genes, as evidenced by quantitative real-time PCR (qRT-PCR), as well as cell cycle arrest.
These data suggest that Ikaros regulates cell cycle progression in leukemia by direct repression of the transcription of the genes that promote cell cycle progression, and identifies one mechanism of Ikaros function as a tumor suppressor in leukemia.
Citation Format: Elanora Dovat, Jonathon Payne, Carlos M.
Casiano, Justin Sloane, Chandrika Gowda, Kimberly J.
Payne, Sinisa Dovat, Chunhua Song.
Regulation of cell cycle progression by Ikaros in leukemia.
[abstract].
In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA.
Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3504.
doi:10.
1158/1538-7445.
AM2014-3504.
Related Results
Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
Transcriptional Regulation of Cell Cycle Progression in T‐Cell Leukemia
The
IKZF1
gene encodes the Ikaros protein that acts as a tumor suppressor in acute lymphoblastic leukemia (ALL). The role of Ikaros in T‐cel...
Abstract 2527: Regulation of mitotic progression in T-cell acute lymphoblastic leukemia by the Ikaros tumor suppressor
Abstract 2527: Regulation of mitotic progression in T-cell acute lymphoblastic leukemia by the Ikaros tumor suppressor
Abstract
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive hematological malignancy that represents a therapeutic challenge. Next-generation sequencing re...
Epigenetic Regulation of Oncogenes in Leukemia by the Ikaros Tumor Suppressor
Epigenetic Regulation of Oncogenes in Leukemia by the Ikaros Tumor Suppressor
The
IKZF1
gene controls expression of the Ikaros protein which functions as a tumor suppressor in pediatric acute lymphoblastic leukemia (AL...
Abstract 5540: Transcriptional control of signaling pathways in T-cell lymphoblastic leukemia by Ikaros tumor suppressor
Abstract 5540: Transcriptional control of signaling pathways in T-cell lymphoblastic leukemia by Ikaros tumor suppressor
Abstract
Cellular proliferation in T-cell acute lymphoblastic leukemia is regulated by multiple signaling pathways. The Phosphoinositide 3-kinase (PI3K)/AKT pathway ...
Abstract 3491: Epigenetic regulation of the RAB5B GTPase expression in B-cell acute lymphoblastic leukemia
Abstract 3491: Epigenetic regulation of the RAB5B GTPase expression in B-cell acute lymphoblastic leukemia
Abstract
Ras analog in brain (Rab) proteins are important parts of small GTPase signaling pathways in human malignancies. RAB5B is the GTPase, which promotes cell...
Regulation of the epigenetic signature in leukemia by Ikaros (800.5)
Regulation of the epigenetic signature in leukemia by Ikaros (800.5)
Ikaros encodes a DNA binding protein that regulates gene expression via chromatin remodeling and epigenetic mechanisms. The loss of Ikaros activity due to genetic or functional ina...
Use of qChIP to identify genes targeted by the Ikaros tumor suppressor
Use of qChIP to identify genes targeted by the Ikaros tumor suppressor
The IKAROS gene encodes a DNA binding zinc finger protein that is essential for hematopoietic differentiation and acts as a tumor suppressor in leukemia. The Ikaros protein is know...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...

